Exact Mass: 353.2355

Exact Mass Matches: 353.2355

Found 27 metabolites which its exact mass value is equals to given mass value 353.2355, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Levomethadyl Acetate

(1S,4S)-4-(Dimethylamino)-1-ethyl-2,2-diphenylpentyl acetic acid

C23H31NO2 (353.2355)


Levomethadyl Acetate is only found in individuals that have used or taken this drug. It is a narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. [PubChem]Opiate receptors (Mu, Kappa, Delta) are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. Opioids also inhibit the release of vasopressin, somatostatin, insulin and glucagon. Levomethadyl acetate effectively opens calcium-dependent inwardly rectifying potassium channels (OP1 receptor agonist), resulting in hyperpolarization and reduced neuronal excitability. N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BC - Drugs used in opioid dependence D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Methadyl Acetate

(3R,6R)-3-Acetoxy-6-dimethylamino-4,4-diphenylheptane

C23H31NO2 (353.2355)


Methadyl Acetate is only found in individuals that have used or taken this drug. It is a narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. [PubChem]Methadyl Acetate is primarily a mu-type opioid receptor agonist. It functions similarily to methadone. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Proadifen

2-(Diethylamino)ethyl 2,2-diphenylpentanoic acid

C23H31NO2 (353.2355)


   

proadifen

proadifen

C23H31NO2 (353.2355)


C471 - Enzyme Inhibitor > C29574 - Nitric Oxide Synthase Inhibitor D004791 - Enzyme Inhibitors

   

1-[1]Naphthyl-cyclohexancarbonsaeure-(2-diaethylamino-aethylester)|1-[1]naphthyl-cyclohexanecarboxylic acid-(2-diethylamino-ethyl ester)

1-[1]Naphthyl-cyclohexancarbonsaeure-(2-diaethylamino-aethylester)|1-[1]naphthyl-cyclohexanecarboxylic acid-(2-diethylamino-ethyl ester)

C23H31NO2 (353.2355)


   

suaveolindole

suaveolindole

C23H31NO2 (353.2355)


A terpenoid indole alkaloid that is 1H-indole substituted by cyclohexylmethyl ring at position 3 which in turn is substituted by additional methyl groups at positions 2 and 3, a propan-2-ylidene group at position 6 and a 2-carboxyethyl group at position 1. Isolated from Greenwayodendron suaveolens, it exhibits antibacterial activity.

   

SCHEMBL13990325

SCHEMBL13990325

C23H31NO2 (353.2355)


   

(8,9-dihydroxy)-3-farnesylindole

(8,9-dihydroxy)-3-farnesylindole

C23H31NO2 (353.2355)


   

1-methyl-2-[9?-oxo-(E)-7?-tridecenyl]-4(1H)-quinolone|euocarpine C

1-methyl-2-[9?-oxo-(E)-7?-tridecenyl]-4(1H)-quinolone|euocarpine C

C23H31NO2 (353.2355)


   

1-methyl-2-[8?-oxo-(E)-9?-tridecenyl]-4(1H)-quinolone|euocarpine D

1-methyl-2-[8?-oxo-(E)-9?-tridecenyl]-4(1H)-quinolone|euocarpine D

C23H31NO2 (353.2355)


   
   

1-methyl-2-[7-carbonyl-(E)-9-tridecenyl]-4(1H)-quinolone

1-methyl-2-[7-carbonyl-(E)-9-tridecenyl]-4(1H)-quinolone

C23H31NO2 (353.2355)


   

(8α,9β-Dihydroxy)-3-farnesylindole

(8α,9β-Dihydroxy)-3-farnesylindole

C23H31NO2 (353.2355)


   

Methadyl acetate

Acetilmetadol [inn-spanish];Acetylmethadol;Acetylmethadolum [inn-latin];Betamethadol

C23H31NO2 (353.2355)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Motretinide

2,4,6,8-Nonatetraenamide,N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (2E,4E,6E,8E)-

C23H31NO2 (353.2355)


D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AD - Retinoids for topical use in acne C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C804 - Retinoic Acid Agent C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

   

3-(2-methoxy-5-methylphenyl)-3-phenyl-N,N-di(propan-2-yl)propanamide

3-(2-methoxy-5-methylphenyl)-3-phenyl-N,N-di(propan-2-yl)propanamide

C23H31NO2 (353.2355)


   

1-[1-(4-Benzyloxyphenyl)-2-(dimethylamino)ethyl]cyclohexanol

1-[1-(4-Benzyloxyphenyl)-2-(dimethylamino)ethyl]cyclohexanol

C23H31NO2 (353.2355)


   

Betacetylmethadol

[(3S,6R)-6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate

C23H31NO2 (353.2355)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

Alphacetylmethadol

(3R,6R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanyl acetate

C23H31NO2 (353.2355)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Monascaminone methyl ether

Monascaminone methyl ether

C23H31NO2 (353.2355)


   

Levacetylmethadol

Levomethadyl Acetate

C23H31NO2 (353.2355)


N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BC - Drugs used in opioid dependence D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

12-(1h-indol-3-yl)-2,6,10-trimethyldodeca-2,6,10-triene-4,5-diol

12-(1h-indol-3-yl)-2,6,10-trimethyldodeca-2,6,10-triene-4,5-diol

C23H31NO2 (353.2355)


   

(1s,12s,15s,17r,20r)-1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraene-15,17-diol

(1s,12s,15s,17r,20r)-1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraene-15,17-diol

C23H31NO2 (353.2355)


   

1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraene-15,17-diol

1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraene-15,17-diol

C23H31NO2 (353.2355)


   

3-[(1r,2s,3s)-2-(1h-indol-3-ylmethyl)-2,3-dimethyl-6-(propan-2-ylidene)cyclohexyl]propanoic acid

3-[(1r,2s,3s)-2-(1h-indol-3-ylmethyl)-2,3-dimethyl-6-(propan-2-ylidene)cyclohexyl]propanoic acid

C23H31NO2 (353.2355)


   

3-[2-(1h-indol-3-ylmethyl)-2,3-dimethyl-6-(propan-2-ylidene)cyclohexyl]propanoic acid

3-[2-(1h-indol-3-ylmethyl)-2,3-dimethyl-6-(propan-2-ylidene)cyclohexyl]propanoic acid

C23H31NO2 (353.2355)


   

(4s,5s,6e,10e)-12-(1h-indol-3-yl)-2,6,10-trimethyldodeca-2,6,10-triene-4,5-diol

(4s,5s,6e,10e)-12-(1h-indol-3-yl)-2,6,10-trimethyldodeca-2,6,10-triene-4,5-diol

C23H31NO2 (353.2355)